Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Equine polyclonal antibodies have shown higher potency in in-vitro studies of SARS-CoV-2 virus neutralisation

expresspharmaNovember 05, 2020

Tag: SARS-CoV-2 , virus , polyclonal antibodies , COVID-19

PharmaSources Customer Service